Advisors Preferred’s Zai Lab ZLAB Stock Holding History

Advisors Preferred’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,948	Closed	-$110K	–	304
2025 Q1	$110K	Buy	+2,948	New	+$90.7K	0.01%	214
2019 Q3	–	Sell	-1,498	Closed	-$54K	–	316
2019 Q2	$54K	Buy	+1,498	New	+$44.1K	0.02%	128

Other funds holding ZLAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Advisors Preferred's ZLAB Position: Q2 2025 in Review

Advisors Preferred sold out of Zai Lab (ZLAB) in Q2 2025, closing a stake of 2,948 shares — an estimated $110K sold.

Advisors Preferred first reported a position in ZLAB in Q2 2019 and held it in 2 quarters. The position peaked at $110K in Q1 2025. 156 funds tracked by Wall St. Rank hold ZLAB as of Q2 2025.

Advisors Preferred reported no remaining Zai Lab position as of Q2 2025 after selling out during the quarter.
Advisors Preferred sold 2,948 Zai Lab shares in Q2 2025, an estimated $110K.
Advisors Preferred first reported a position in Zai Lab in Q2 2019 and held it in 2 quarters.
Advisors Preferred's Zai Lab position peaked at $110K in Q1 2025.
156 funds tracked by Wall St. Rank held Zai Lab as of Q2 2025.

Based on Advisors Preferred's 13F filing for Q2 2025, filed 5 Aug 2025.